Business, energy, technology, markets and global industry news from Business News Today

Blackstone

PharmaDeviceNews Blackstone
KKR’s $5.7 billion acquisition of Integer Holdings highlights growing private-equity interest in specialised medical-device manufacturing and regulated healthcare infrastructure. Representative image.
Features & Analysis

KKR is paying $5.7bn for Integer Holdings. Why are medtech suppliers suddenly so attractive to private equity?

KKR’s agreement to acquire Integer Holdings joins the multibillion-dollar privatisation of Hologic and American Industrial Partners’ purchase of Avanos Medical. The transactions differ substantially, but together they show why specialised medtech manufacturers, platforms and established healthcare franchises remain attractive to private capital even when near-term growth is uneven.

Read More
Medical Devices & Diagnostics

Hologic wins key Siemens patent fight as breast imaging market enters sharper phase

Find out how Hologic’s patent victory against Siemens Healthineers could reshape breast cancer detection technology and medtech competition.

Read More
Representative image: Angelini Pharma’s $4.1 billion Catalyst Pharmaceuticals acquisition highlights the growing race for rare disease and neurology assets, with Firdapse, Agamree and U.S. commercial scale at the center of the deal.
Pharma & Biotech

Angelini Pharma bets $4.1bn on rare neurology scale with Catalyst Pharmaceuticals

Angelini gains U.S. rare disease scale. Catalyst gets certainty, but Firdapse concentration keeps the real test ahead.

Read More